Compare PICS & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PICS | BLFS |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2021 | 2013 |
| Metric | PICS | BLFS |
|---|---|---|
| Price | $10.19 | $36.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $22.00 | ★ $32.00 |
| AVG Volume (30 Days) | 538.1K | ★ 615.6K |
| Earning Date | 05-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $33.65 | $19.73 |
| Revenue Next Year | $39.85 | $17.82 |
| P/E Ratio | ★ $29.44 | $39.57 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $8.32 | $17.86 |
| 52 Week High | $18.49 | $38.10 |
| Indicator | PICS | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 69.74 |
| Support Level | $9.85 | $23.63 |
| Resistance Level | $11.50 | $38.10 |
| Average True Range (ATR) | 0.78 | 0.89 |
| MACD | -0.10 | -0.08 |
| Stochastic Oscillator | 10.27 | 63.33 |
PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.